Signal-Specific Transcription Factors Shaping the Tumor Immune Microenvironment
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Signaling".
Deadline for manuscript submissions: closed (20 November 2021) | Viewed by 33650
Special Issue Editor
Interests: c-Jun/Ap-1 transcription factor; transcriptional regulation; signal transduction; cell death; cancer signaling; tumor microenvironment; GPER signaling
Special Issue Information
Dear Colleagues,
A growing number of evidence indicates that communication between tumor cells and the surrounding heterogeneous population of stromal cells is crucial for cancer progression and metastasis. In particular, both tumor cells and cancer-associated fibroblasts (CAFs) deregulate the immune-activity of tumor-infiltrating lymphocytes and macrophages, hence counteracting the anti-cancer immune response. Immunosuppressive traits of the tumor microenvironment (TME) are mainly induced by tumor cell surface immunomodulatory proteins (checkpoint proteins), along with various factors (cytokines, chemokines, growth-factors, etc.), metabolites and exosomal microRNA produced by either cancer cells or CAFs.
A major mechanism mediating the immunosuppressive effects of TME factors is the alteration of transcriptomic profiles associated with cytotoxic T–cell activation, Treg/Th1/Th17 balance and M1/M2 macrophage polarization. The transcriptional regulation of T cell fate or macrophage polarization is mediated by signal-inducible transcription factors (iTFs), which acts together with epigenetic histone modifications to define chromatin accessibility for lineage-specific TFs at specific enhancers. Conversely, the loss (or gain) of signal-specific iTFs in tumor-infiltrating immune cells may alter chromatin accessibility at specific enhancers, switching the original immune-activity of T cells or macrophages. Further elucidation of the TME signaling pathways affecting transcriptional regulation in tumor-infiltrating immune cells will certainly open new therapeutic roads, which may complement current checkpoint immunotherapy.
In this Special Issue of Cells, we invite contributors to submit original research articles or reviews leading to further insights into possible mechanisms linking TME signaling molecules, such as hormones and cytokines, to the cross-regulation between iTFs and chromatin modifiers shaping the cellular fate of tumor-infiltrating immune cells.
Prof. Anna Maria Musti
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tumor immunity
- cancer-associated fibroblasts
- tumor-infiltating immune cells
- inducible transcription factors
- chromatin accessibility
- receptor signaling
- signal transduction
- T cell exhaustion
- Th polarization
- macrohage polarization
- cytokines
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.